Cagrilintide 10mg is a long-acting synthetic analog of amylin, a peptide hormone naturally co-secreted with insulin by pancreatic beta cells. In simple terms, it is studied in metabolic research because amylin plays a role in how the body regulates satiety signaling, gastric emptying, and glucose-related pathways in controlled biological systems. Researchers use compounds like Cagrilintide …
$65.00
Cagrilintide is a long-acting synthetic analog of amylin, a peptide hormone naturally co-secreted with insulin by pancreatic beta cells. In simple terms, it is studied in metabolic research because amylin plays a role in how the body regulates satiety signaling, gastric emptying, and glucose-related pathways in controlled biological systems. Researchers use compounds like Cagrilintide to better understand how amylin receptor activation influences energy balance and metabolic signaling at the cellular and physiological levels.
From a technical standpoint, Cagrilintide is a dual amylin and calcitonin receptor agonist (DACRA), engineered to have increased stability and prolonged receptor activity compared to native amylin. It is a modified peptide designed to resist rapid enzymatic degradation, allowing for extended interaction with amylin receptor complexes (AMY receptors), which are composed of calcitonin receptor (CTR) and receptor activity-modifying proteins (RAMPs). In preclinical and clinical research settings, Cagrilintide has been evaluated for its effects on gastric motility, appetite-regulating hormone pathways, and glycemic response modulation mechanisms.
Cagrilintide is strictly intended for laboratory and research use only. It is not approved for human consumption, medical treatment, or diagnostic applications.
This compound is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use. Proper handling and regulatory compliance are required by the purchaser.
